October 22, 2017 12:08 AM ET

Healthcare Equipment and Supplies

Company Overview of Neuravi Limited

Company Overview

Neuravi Limited designs and develops clot retrieval devices for restoring blood flow in patients who have suffered ischemic strokes due to blockage of an artery to the brain. It offers EmboTrap revascularization devices for the treatment of acute ischemic strokes to patients in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Spain, Sweden, and Switzerland. The company was incorporated in 2009 and is based in Galway, Ireland. As of April 10, 2017, Neuravi Limited operates as a subsidiary of DePuy Ireland Unlimited Company.

Parkmore Business Park West



Founded in 2009


353 9 139 4114


353 9 139 4025

Key Executives for Neuravi Limited

Chief Executive Officer
Chief Technology Officer
Vice President of U.S. Sales and Marketing
Age: 58
Compensation as of Fiscal Year 2017.

Neuravi Limited Key Developments

Neuravi Limited Presents at BioCapital Europe 2017, Mar-15-2017 03:20 PM

Neuravi Limited Presents at BioCapital Europe 2017, Mar-15-2017 03:20 PM. Venue: Sofitel Legend Amsterdam The Grand, Oudezijds Voorburgwal 197, 1012 EX Amsterdam, Netherlands.

Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke

Neuravi announcedcompletion of enrollment in the company’s international clinical trial assessing the safety and effectiveness of the EmboTrap®II Revascularization Device, an advanced stent retriever platform for the treatment of acute ischemic stroke. Data from the pivotal study, called ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap), will be submitted as part of an application to U.S. Food and Drug Administration (FDA) for market clearance of the device in the United States. The ARISE II study enrolled 228 patients in 19 enrolling sites across the United States and Europe. Sam Zaidat, M.D., Stroke and Neuroscience Medical Director of St. Vincent Mercy Hospital in Toledo, Ohio, is the study’s principal investigator. The study enrolled ahead of schedule, with enrollment led by Dr. Hormozd Bozorgchami’s team at Oregon Health Sciences University in Portland and Dr. Marc Ribo’s team at Vall d’Hebron in Barcelona. The EmboTrap platform is designed to restore blood flow to the brain by retrieving and retaining clot with a proprietary dual-layer stent-like structure.

Neuravi Reports EUR 15 Million in Venture Debt Financing from IPF Partners

Neuravi reported EUR 15 million in venture debt financing from IPF Partners. This financing allows Neuravi to invest in U.S. commercialization and stroke treatment portfolio expansion, building upon successful commercialization of the company's EmboTrap Revascularization Device in Europe and rapid progress enrolling the ARISE II U.S. pivotal study. The company said that landmark acute stroke clinical trials published in 2014 and 2015 demonstrating the superiority of stent retriever technology in treating large vessel strokes have driven a surge in the number of stent retriever procedures.

Similar Private Companies By Industry

Company Name Region
Advanced Surgical Concepts Limited Europe
Aegis Surgical Limited Europe
Aerogen Limited Europe
AeroSurgical Ltd. Europe
AltaScience Limited Europe

Recent Private Companies Transactions

April 10, 2017
Private Placement
November 2, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neuravi Limited, please visit www.neuravi.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.